Literature DB >> 7616855

Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion?

K Ishida1, A Mizuno, Z Min, T Sano, K Shima.   

Abstract

To identify the primary disorder causing diabetes mellitus in a model rat (Otsuka Long-Evans Tokushima Fatty [OLETF]) with non-insulin-dependent diabetes mellitus (NIDDM), we studied the temporal relationship between insulin resistance and impairment of pancreatic beta-cell function. Groups of 28 male OLETF rats and male nondiabetic control Long-Evans Tokushima Otsuka (LETO) rats were given an intravenous (i.v.) glucose and glucagon tolerance test (IVGTT) and hyperinsulinemic euglycemic clamp tests at 10, 16, 24, and 40 weeks of age. After the euglycemic clamp test, abdominal fat was measured and the pancreas was examined histologically. At 16 weeks of age, insulin-mediated whole-body glucose uptake as measured by the hyperinsulinemic euglycemic clamp technique was significantly reduced in OLETF rats (glucose infusion rat [GIR], 40.9 +/- 4.2 mumol/kg.min) as compared with LETO rats (78.4 +/- 6.9). On the other hand, plasma insulin responses to glucose and glucagon in OLETF rats were higher than those in LETO rats at 16 and 24 weeks of age, but clearly decreased at 40 weeks of age (sigma immunoreactive insulin [IRI] to glucagon, 8.81 +/- 1.81 v 27.32 +/- 4.59 nmol.min in OLETF and LETO rats, respectively, P < .01). Abdominal fat deposition was significantly greater in OLETF rats than in LETO rats at all ages tested except 10 weeks. Pancreatic islets of OLETF rats became enlarged and fibrotic. These results demonstrated that insulin resistance preceded impairment of pancreatic beta-cell function in OLETF rats, and that insulin resistance seemed closely related to fat deposition in the abdominal cavity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616855     DOI: 10.1016/0026-0495(95)90249-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Proteomic Analysis of Extracellular Vesicles Released by Adipocytes of Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.

Authors:  Jeong-Eun Lee; Pyong-Gon Moon; In-Kyu Lee; Moon-Chang Baek
Journal:  Protein J       Date:  2015-06       Impact factor: 2.371

2.  Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Catherine R Mikus; R Scott Rector; Arturo A Arce-Esquivel; Jessica L Libla; Frank W Booth; Jamal A Ibdah; M Harold Laughlin; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2010-07-15

3.  Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats.

Authors:  F Saito; M Kawaguchi; J Izumida; T Asakura; K Maehara; Y Maruyama
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

Review 4.  Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Noriaki Nagai; Yoshimasa Ito
Journal:  World J Diabetes       Date:  2013-12-15

Review 5.  Acute and chronic animal models for the evaluation of anti-diabetic agents.

Authors:  Suresh Kumar; Rajeshwar Singh; Neeru Vasudeva; Sunil Sharma
Journal:  Cardiovasc Diabetol       Date:  2012-01-19       Impact factor: 9.951

6.  Dysregulation of dimethylargininedimethylaminohydrolase/asymmetric dimethylarginine pathway in rat type II diabetic nephropathy.

Authors:  Ying-Ling Lai; Sae Aoyama; Miyuki Ohata; Nami Otsuka; Hidemi Shiokawa; Susumu Tomono; Yukio Fujiwara; Hiroaki Kanazawa; Noriyuki Miyoshi; Hiroshi Ohshima
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

7.  Reduced food intake is the major contributor to the protective effect of rimonabant on islet in established obesity-associated type 2 diabetes.

Authors:  Sang-Man Jin; Bae Jun Oh; Suel Lee; Jung Mook Choi; Soo Jin Yang; Sung Woo Park; Kwang-Won Kim; Jae Hyeon Kim; Cheol-Young Park
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.